IE33109L - Pharmaceutical preparation - Google Patents

Pharmaceutical preparation

Info

Publication number
IE33109L
IE33109L IE690009A IE969A IE33109L IE 33109 L IE33109 L IE 33109L IE 690009 A IE690009 A IE 690009A IE 969 A IE969 A IE 969A IE 33109 L IE33109 L IE 33109L
Authority
IE
Ireland
Prior art keywords
acetonide
contain
acid
psoriasis
flumethasone
Prior art date
Application number
IE690009A
Other versions
IE33109B1 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IE33109L publication Critical patent/IE33109L/en
Publication of IE33109B1 publication Critical patent/IE33109B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

1,225,830. Anti-psoriasis compositions. CIBA Ltd. 31 Dec., 1968 [8 Jan., 1968], No. 61909/ 68. Heading A5B. Pharmaceutical preparations, e.g. ointments, creams, pastes, foams, lotions and aerosol sprays, for the treatment of psoriasis, contain a dermatologically active steroid, and a triester of dithranol (1,8,9-trihydroxyanthracene) with a C 1-6 alkanoic acid unsubstituted or substituted by halogen and/or C 1-6 alkyl, in admixture or conjunction with a pharmaceutically suitable carrier. Triacetyldithranol is preferred. Suitable steroids include hydrocortisone, prednisolone, fluocortolone, fluorohydrocortisone, dexamethasone, betamethasone, triamcinoline and its acetonide, fluorometholone, 3, 20-dioxo- 6-fluoro-11, 16, 17, 21-tetrahydroxypregna-#<SP>4</SP>- en-16, 17-acetonide, fluocinolone acetonide and flumethasone or their esters with alkanecarboxylic acids or with inorganic acids, e.g. phosphoric or sulpuric acid, such as flumethasone pivalate. The preparations may also contain a keratolytic, e.g. salicyclic acid, antibiotics, antimycotics or antiseptics.
IE9/69A 1968-01-08 1969-01-02 Pharmaceutical preparations IE33109B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH19868 1968-01-08

Publications (2)

Publication Number Publication Date
IE33109L true IE33109L (en) 1969-07-08
IE33109B1 IE33109B1 (en) 1974-03-20

Family

ID=4181484

Family Applications (1)

Application Number Title Priority Date Filing Date
IE9/69A IE33109B1 (en) 1968-01-08 1969-01-02 Pharmaceutical preparations

Country Status (7)

Country Link
BE (1) BE726574A (en)
DE (1) DE1817288A1 (en)
FR (1) FR2000053A1 (en)
GB (1) GB1225830A (en)
IE (1) IE33109B1 (en)
IL (1) IL31289A (en)
NL (1) NL6900235A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565966B1 (en) * 1984-06-13 1986-08-29 Cird ARYL-10 DIHYDROXY-1,8 ANTHRONES AND THEIR ESTERS, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS
DE50005922D1 (en) * 2000-11-14 2004-05-06 Benkert Eugen Georg Topical antipsoriaticum with urea, a corticoid and a disinfectant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070949A (en) * 1964-10-16 1967-06-07 Hyman Yarrow Topical compositions for the treatment of psoriasis

Also Published As

Publication number Publication date
BE726574A (en) 1969-07-07
DE1817288A1 (en) 1969-08-07
IE33109B1 (en) 1974-03-20
NL6900235A (en) 1969-07-10
IL31289A (en) 1974-01-14
GB1225830A (en) 1971-03-24
FR2000053A1 (en) 1969-08-29
IL31289A0 (en) 1969-02-27

Similar Documents

Publication Publication Date Title
US4267173A (en) Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
NO164905C (en) PROCEDURE FOR THE PREPARATION OF 16,17-ACETAL PREGNANCY DERIVATIVES.
US4172132A (en) 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
US3073743A (en) Antiinflammatory steroid acetonide compositions and therapy
US3755302A (en) Process for the production of 17-monesters of 17{60 , 21-dihydroxy-steroids and products thereof
US2736681A (en) Chemical compounds
GB1472308A (en) Steroidal topical cream base
US4576936A (en) 6α-Fluoro-9α-chloro-prednisolone 17,21-diesters
IE39738B1 (en) Novel triamcinolone derivative
US3984544A (en) Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor
IE33109L (en) Pharmaceutical preparation
IE41287B1 (en) Topical steroid formulation
US3694471A (en) 17-valerate ester of 6{60 ,9{60 -difluorohydrocortisone, its compositions and use as an anti-inflammatory agent
GB1232745A (en)
US3824260A (en) Novel pregnanoic acid derivatives
GB1187395A (en) Terpenic, Homoterpenic and Terpenylacetic Acid Esters ofSteroid 21-ols
GB1527061A (en) Anti-inflammatory compositions containing steroids
US4185101A (en) 1,3,5(10),6,8-19-Nor-pregnapentaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
US3857941A (en) Pharmaceutical compositions and use of prednisolone 17-benzoate
GB963938A (en) New steroid esters
GB1511820A (en) 16-methyl-9alpha-halo steroid ethers and esters and their preparation
GB1318279A (en) Steroid compositions
GB1430223A (en) Anti-inflammatory composition comprising steroids
GB2018257A (en) 11 beta -Silylation in corticoid synthesis
US3415855A (en) Trichloro pregnadienes and esters thereof